http://rdf.ncbi.nlm.nih.gov/pubchem/reference/5158685

Outgoing Links

Predicate Object
contentType Clinical Trial|Journal Article|Research Support, Non-U.S. Gov't
endingPage 1851
issn 1347-4820
1346-9843
issueIdentifier 11
pageRange 1844-1851
publicationName Circulation journal : official journal of the Japanese Circulation Society
startingPage 1844
bibliographicCitation Yamamoto H, Takahashi K, Watanabe H, Yoshikawa Y, Shirakawa R, Higashi T, Kawato M, Ikeda T, Tabuchi A, Morimoto T, Kita T, Horiuchi H. Evaluation of the antiplatelet effects of cilostazol, a phosphodiesterase 3 inhibitor, by VASP phosphorylation and platelet aggregation. Circ J. 2008 Nov;72(11):1844–51. doi: 10.1253/circj.cj-08-0289. PMID: 18832777.
creator http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_1dc89b7b20860727e746a733c3119b99
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_c27d5b5b7d2ca50ceffc2013fc67e15f
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_ff9c149033d5c047c2ac2ff3660061a8
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_e5d5ffaeae532ee95f1841f20d15e6ac
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_d612344063129b534053f3a074a1c7e4
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_3b53342578b61bf91cd0fccaefc304a0
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_7599f4b67472d67ecc9fd975fe92efbf
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_c4240d0ff160349ff8f4d7cc104e0576
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_1cd2bd341f1a92588995aa05c0a2b2fc
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_dbf6a96fcce366f3ee8d06e62f8d356c
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_25c1a174f998b05c39a20a722494f85d
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_fd5d99f955d0f688401f222047245a82
date 200811
identifier https://doi.org/10.1253/circj.cj-08-0289
https://pubmed.ncbi.nlm.nih.gov/18832777
isPartOf https://portal.issn.org/resource/ISSN/1346-9843
http://rdf.ncbi.nlm.nih.gov/pubchem/journal/27033
https://portal.issn.org/resource/ISSN/1347-4820
language English
source https://pubmed.ncbi.nlm.nih.gov/
https://www.crossref.org/
title Evaluation of the Antiplatelet Effects of Cilostazol, a Phosphodiesterase 3 Inhibitor, by VASP Phosphorylation and Platelet Aggregation
discusses http://id.nlm.nih.gov/mesh/M0016705
http://id.nlm.nih.gov/mesh/M0545666
http://id.nlm.nih.gov/mesh/M0000811
http://id.nlm.nih.gov/mesh/M0017012
http://id.nlm.nih.gov/mesh/M0024220
http://id.nlm.nih.gov/mesh/M0232069
http://id.nlm.nih.gov/mesh/M0132637
http://id.nlm.nih.gov/mesh/M0021253
http://id.nlm.nih.gov/mesh/M0013781
hasPrimarySubjectTerm http://id.nlm.nih.gov/mesh/D015815Q000378
http://id.nlm.nih.gov/mesh/D013777Q000008
http://id.nlm.nih.gov/mesh/D010974Q000187
http://id.nlm.nih.gov/mesh/D010975Q000008
http://id.nlm.nih.gov/mesh/D001792Q000378
http://id.nlm.nih.gov/mesh/D058987
http://id.nlm.nih.gov/mesh/D008840Q000378
http://id.nlm.nih.gov/mesh/D010750Q000378
hasSubjectTerm http://id.nlm.nih.gov/mesh/D000328
http://id.nlm.nih.gov/mesh/D008875
http://id.nlm.nih.gov/mesh/D000527Q000494
http://id.nlm.nih.gov/mesh/D000077407
http://id.nlm.nih.gov/mesh/D010766Q000187
http://id.nlm.nih.gov/mesh/D006801
http://id.nlm.nih.gov/mesh/D008297
discussesAsDerivedByTextMining http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6022
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_caa134bb5c59c595b9e243985fd916f3
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/EC_3.1.4.1
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6076
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5280723
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7065
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2754
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7181

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129170378
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127976521
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID7408

Total number of triples: 66.